Le Lézard
Classified in: Health, Business
Subject: TNM

Cherry Creek Dermatology Joins Epiphany Dermatology


AUSTIN, Texas, July 16, 2018 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded into Colorado through its acquisition of Cherry Creek Dermatology. Epiphany Dermatology is comprised of leading dermatologists committed to improving access to exceptional dermatologic care, with clinics in Arizona, Iowa, Missouri, New Mexico, Oklahoma, Texas, and now Colorado.

Founded in 1988 by J. Michael Maloney, MD, Cherry Creek Dermatology has a long-established reputation providing high quality dermatology services to patients in the greater Denver area. Through this acquisition, Cherry Creek's dedicated providers and support staff have joined Epiphany in a partnership grounded in exceptional patient care.

Dr. Maloney, a board-certified dermatologist who earned his medical degree and completed his dermatology residency at Tulane University School of Medicine, commented, "My staff and I are excited to join the Epiphany team.  Epiphany's values and culture align nicely with Cherry Creek Dermatology.  By forming a partnership with Epiphany, we will expand our ability to provide for the dermatologic needs of our community.  Epiphany has the infrastructure and expertise to help us manage the burdens of running the practice, which allows us to focus on taking care of our patients and serving the community."    

Gheorghe Pusta, Chief Executive Officer of Epiphany, said, "We are pleased to welcome Dr. Maloney and his team of caring professionals from Cherry Creek Dermatology to Epiphany Dermatology. Dr. Maloney and his team are as committed as we are to delivering clinical excellence in a caring, collaborative, and common-sense environment. Cherry Creek is an exciting opportunity to expand our provider network and improve access to great dermatologic care in the Colorado market."  

Through this partnership, Cherry Creek's providers and staff gain additional resources to help with operations, managed care, marketing, compliance, human resources, recruiting, IT, and many other support services.

About Epiphany Dermatology

Epiphany Dermatology is a rapidly expanding dermatology company, driven by a passion to improve access to high quality dermatologic care in a values-based manner. Through its partnership with leading dermatologists across 37 locations in Arizona, Colorado, Iowa, Missouri, New Mexico, Oklahoma, and Texas, Epiphany provides general dermatology, skin cancer care, Mohs surgery, cosmetic services, and additional dermatologic services.  Epiphany raises the standard of dermatology care by making clinical excellence accessible to all patients, promptly and in a warm and inviting environment.  Epiphany Dermatology is headquartered in Austin, Texas. For more details, please visit www.epiphanydermatology.com or call (512) 628-0465.

Ted Emmert
Chief Development Officer
Epiphany Dermatology
(512) 628-0465
[email protected]

Gheorghe Pusta
Chief Executive Officer
Epiphany Dermatology
(512) 628-0465
[email protected]

SOURCE Epiphany Dermatology


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: